美國腦積水分流器市場規模和預測、區域佔有率、趨勢和成長機會分析報告範圍：按產品、類型、年齡層和最終用戶

美國腦積水分流器市場規模預計將從 2022 年的 1.09 億美元增至 2030 年的 1.46 億美元。預計 2022 年至 2030 年該市場將以 3.7% 的年複合成長率成長。

市場概況：

腦積水有多種治療方案，包括：

分流系統：這是一種常見的治療方法，植入分流器（一根細管），將多餘的腦脊髓液從大腦轉移到身體的另一個可以吸收的部位。分流技術可能已經取得了進步，以提高其有效性並減少併發症。

內視鏡第三腦室造口術（ETV）：這是一種外科手術，在大腦第三腦室底部開一個小孔，讓多餘的腦脊髓液流出並被吸收。 ETV 用於某些非交通性腦積水病例。

導管腦室造口術：另一種手術選擇是將導管直接插入腦室以排出多餘的腦脊髓液。

腦室內內視鏡檢查：內視鏡檢查等微創技術的進步使得腦積水的診斷和治療更加精確。

加強治療腦積水的合作

美國腦積水分流器市場公司正在實施合資和合作等策略，以擴大其市場佔有率。 2020 年，Aesculap, Inc. 與 Christoph Miethke GmbH & Co. KG (MIETHKE) 合作，共同宣佈在美國推出 M.blue 腦積水閥。其獨特的重力技術與閥門中的固定壓差裝置整合在一起，可在患者最活躍的時間根據位置對開啟壓力進行簡單的調整。許多市場參與者專注於開發“智慧分流器”，以了解隨時間變化的流量或體積速率。一些行業合作夥伴也在開發使用熱稀釋來估計通過遠端導管的流量以診斷分流故障的設備。因此，越來越多的合作夥伴有助於腦積水分流器的智慧運作，這將導致美國腦積水分流器市場未來的新趨勢。

提高分流品質的研究不斷深入

研究人員一直在開發改良的分流材料，以降低阻塞、感染和其他併發症的風險。

抗菌塗層：研究人員一直在研究具有抗菌特性的分流器塗層。這些塗層可以幫助降低植入分流器時感染的風險。

防堵塞機制：有些分流器設計包含防止或減輕阻塞的功能。例如，具有防虹吸機制的閥門可以幫助保持適當的流量並防止過度排水或堵塞。

電磁閥調節：一些分流系統使用磁鐵以非侵入性方式調節閥門設置，從而減少重複手術的需要。

生物相容性材料：在分流器結構中使用生物相容性材料可以最大限度地減少身體過敏反應或其他不良反應的風險。

遠端監控：遠端監控技術的進步可以追蹤分流性能和顱內壓，幫助醫療保健提供者在問題變得嚴重之前發現問題。

奈米技術：奈米技術應用已被探索用於製造可抵抗細菌黏附並提高分流器整體耐用性的分流器組件。

例如，2021 年，賓州州立大學的研究人員一直在積極研究一項名為 HydroFix 的突破性技術。這種創新的手術分流系統專門設計用於解決與市場上現有分流裝置相關的眾多風險。其主要目標是為正常壓力腦積水 (NPH) 患者提供持久的治療解決方案。為了推進這項技術，研究人員成立了一家名為 Cranial Devices Inc. 的新創公司。他們目前正在向賓州州立大學尋求 HydroFix 技術的許可。

同樣，Rhaeos, Inc.（一家臨床階段的醫療設備公司）正在開發 FlowSense，這是一項專利技術和一種非侵入性無線穿戴式皮膚貼片。 FlowSense 是一種無線、非侵入性熱流量感測器，安裝在患者頸部分流器上方，用於檢測腦脊髓液的存在和大小。透過 FlowSense，可以在診所、住院環境和急診室監測分流功能，從而減少不必要的影像、住院時間和再入院成本。

美國腦積水分流器市場：細分概述

美國腦積水分流器市場成長依產品、類型、年齡層和最終用戶細分。依產品，市場分為腦積水瓣膜、腦積水導管、神經導航系統等。腦積水閥進一步分為可調式壓力閥和固定壓力閥。就類型而言，美國腦積水流器市場分為腦室腹膜分流器、腦室心房分流器、腦室胸膜分流器和腰腹膜分流器。腦室腹腔細分市場將在 2022 年引領市場，並預計在預測期內將保持其主導地位。腦室腹膜 (VP) 分流術透過將腦脊髓液從腦室轉移到腹膜腔（靠近消化器官的腹部狹縫）來減少積液對大腦造成的壓力。腦室腹膜（VP）分流術是治療腦積水最常用的工具之一。根據國家生物技術資訊中心 (NCBI) 發表的一篇研究論文，VP 分流對高級神經外科患者護理有重大影響。 VP 分流術可以挽救良性疾病的生命。

美國腦積水流器市場依年齡層分為兒童和成人。兒科細分市場將在 2022 年引領市場，預計到 2030 年將在預測期內保持主導地位。腦積水是兒童腦部手術最常見的原因。建議進行產前超音波檢查或 MRI 掃描來識別生長中胎兒的腦積水。嬰兒通常表現出進行性大頭畸形的體徵，而 2 歲以上的兒童則表現出顱內高壓的體徵和症狀。如果不及時治療，小兒腦積水可能會很危險。然而，透過早期診斷和治療，兒童通常可以過著正常、健康的生活。據腦積水協會稱，在美國，每 1,000 名嬰兒中就有 1-2 名患有腦積水。

美國腦積水流器市場依最終用戶分類為醫院、門診手術中心等。醫院細分市場將在 2022 年引領市場，預計到 2030 年將在預測期內保持主導地位。醫院透過複雜但專業的科學設備為人們提供醫療保健。這些設施分為一般機構、專業機構或政府機構。醫院為患有各種疾病的患者群體提供醫療服務，並發揮重要作用。美國醫院腦積水流器市場的成長歸因於神經外科手術數量的增加，以及這些設施中用於治療這種情況的瓣膜和神經導航系統的需求激增。此外，已開發國家和發展中國家越來越多的醫院提供腦積水手術預計將推動未來市場的成長。

美國腦積水流器市場：關鍵參與者

B. Braun SE、Sophysa SA、Integra LifeSciences Holdings Corp、KANEKA MEDIX CORP、Medtronic Plc、Natus Medical Inc、Anuncia Inc、Desu Medical 是美國腦積水分流器市場的領先公司。

在準備美國腦積水分流器市場報告時提到的一些主要和次要來源包括世界衛生組織(WHO)、FDA（食品和藥物管理局）、腦積水協會、國家神經疾病和中風研究所( NINDS) ）、加州大學、洛杉磯衛生組織、國家生物技術資訊中心、橘郡兒童健康中心等。

目錄

第 1 章：簡介

• Insight Partners 研究報告指南
• 市場區隔

第 2 章：研究方法

• 覆蓋範圍
• 二次研究
• 初步研究

第 3 章：美國腦積水流體器市場 - 市場格局

• 概述
  • 美國PEST分析

第 4 章：美國腦積水流體器市場 - 主要市場動態

• 市場促進因素
  • 腦積水盛行率激增
  • 腦積水治療設備的進展
• 市場限制
  • 治療費用高且需要修改手術
• 市場機會
  • 與腦積水流相關的研發和試驗經費增加
• 未來的趨勢
  • 加強合作以幫助腦積水分流器的智慧運作
• 影響分析

第 5 章：美國腦積水分流器市場 - 國家分析

第 6 章：腦積水流量市場 - 收入和 2030 年預測 - 按產品

• 概述
• 2022 年及 2030 年美國腦積水分流器市場收入佔有率（按產品分類）
• 腦積水瓣膜
• 腦積水導管
• 神經導航系統
• 其他

第 7 章：美國腦積水分流器市場 - 收入和 2030 年預測 - 按類型

• 概述
• 美國腦積水分流器市場收入佔有率，按類型 2022 年和 2030 年 (%)
• 腦室腹膜
• 心室房
• 腦室胸膜
• 腰腹膜

第 8 章：美國腦積水流量市場 - 收入和 2030 年預測 - 按年齡層

• 概述
• 2022 年及 2030 年美國腦積水分流器市場收入佔有率（按年齡層）（%）
• 兒科
• 成年人

第 9 章：美國腦積水流量市場 - 收入和 2030 年預測 - 按最終用戶

• 概述
• 2022 年及 2030 年美國腦積水分流器市場收入佔有率（按最終用戶分類）（%）
• 醫院
• 門診手術中心
• 其他

第 10 章：產業格局

• 概述
• 有機發展
  • 概述

第 11 章：公司簡介

• B. Braun SE
• Sophysa SA
• Integra LifeSciences Holdings Corp
• KANEKA MEDIX CORP.
• Medtronic Plc
• Natus Medical Inc
• Anuncia Inc.
• Desu Medical

第 12 章：附錄

• 關於 Insight Partners
• 專業術語

The US Hydrocephalus Shunts market size is expected to reach US$ 0.146 billion by 2030 from US$ 0.109 billion in 2022. The market is estimated to grow at a CAGR of 3.7% from 2022 to 2030.

Market Overview:

There are several treatment options available for hydrocephalus, including:

Shunt Systems: This is a common treatment where a shunt (a thin tube) is implanted to divert excess cerebrospinal fluid from the brain to another part of the body where it can be absorbed. There may have been advancements in shunt technology to improve their effectiveness and reduce complications.

Endoscopic Third Ventriculostomy (ETV): This is a surgical procedure where a small hole is made in the floor of the third ventricle of the brain to allow excess cerebrospinal fluid to flow out and be absorbed. ETV is used in certain cases of non-communicating hydrocephalus.

Ventriculostomy with Catheter: Another surgical option involves inserting a catheter directly into the brain's ventricles to drain excess cerebrospinal fluid.

Intraventricular Endoscopy: Advances in minimally invasive techniques like endoscopy have allowed for more precise diagnosis and treatment of hydrocephalus.

Increasing Partnerships to Treat Hydrocephalus

US hydrocephalus shunts market companies are implementing strategies such as joint ventures and partnerships to extend their market shares. In 2020, Aesculap, Inc., partnered with Christoph Miethke GmbH & Co. KG (MIETHKE), and together they announced the launch of the M.blue hydrocephalus valve in the US. Its unique gravity technology is integrated with a fixed differential pressure unit in a valve, enabling a simple, position-dependent adjustment of the opening pressure during the patient's most active time. Many market players are focused on developing "smart shunts" that could provide an understanding of flow or volume rates over time. Several industry partners are also developing devices that use thermodilution to estimate flow through a distal catheter to diagnose shunt malfunction. Thus, the increasing number of partnerships to aid in smart functioning of hydrocephalus shunts would lead to new future trends in the US hydrocephalus shunts market.

Growing Research to Improve the Quality of Shunts

Researchers have been developing improved shunts materials to reduce the risk of blockages, infections, and other complications.

Antibacterial Coatings: Researchers have been investigating coatings for shunts that have antibacterial properties. These coatings can help reduce the risk of infection when the shunt is implanted.

Anti-Blockage Mechanisms: Some shunt designs incorporate features to prevent or mitigate blockages. For example, valves with anti-siphon mechanisms can help maintain proper flow and prevent over-drainage or blockages.

Magnetic Valve Adjustments: Some shunt systems use magnets to adjust valve settings non-invasively, reducing the need for repeated surgeries.

Biocompatible Materials: The use of biocompatible materials in shunt construction can minimize the risk of allergic reactions or other adverse responses from the body.

Remote Monitoring: Advancements in remote monitoring technology have allowed for tracking shunt performance and intracranial pressure, helping healthcare providers identify issues before they become severe.

Nanotechnology: Nanotechnology applications have been explored for creating shunt components that resist bacterial adhesion and improve the overall durability of the shunt.

For instance, in 2021, Penn State researchers have been actively working on a groundbreaking technology called HydroFix. This innovative surgical shunt system is specifically designed to address the numerous risks associated with existing shunt devices available in the market. Its primary aim is to offer a long-lasting treatment solution for patients with Normal Pressure Hydrocephalus (NPH). To advance this technology, the researchers established a startup called Cranial Devices Inc. They are currently in the process of seeking a license for the HydroFix technology from Penn State University.

Similarly, Rhaeos, Inc., a clinical-stage medical device company, is developing FlowSense, a patented technology and a noninvasive wireless, wearable skin patch. FlowSense is a wireless, noninvasive thermal flow sensor that is mounted on a patient's neck overlying the shunt to detect the presence and magnitude of CSF. With FlowSense, shunt function can be monitored in clinics, in-patient settings, and emergency departments, thereby reducing unnecessary imaging, hospital length of stay, and readmission costs.

US Hydrocephalus Shunts Market: Segmental Overview

The US hydrocephalus shunts market growth is segmented into product, type, age group, and end-user. On the basis of product, the market is segmented into hydrocephalus valves, hydrocephalus catheters, neuronavigation systems, and others. The hydrocephalus valves is further segmented into adjustable pressure valves, and fix pressure valves. In terms of type, the US hydrocephalus shunts market is segmented into ventriculoperitoneal, ventriculoatrial, ventriculopleural, and lumboperitoneal. The ventriculoperitoneal segment led the market in 2022 and is expected to retain its dominance during the forecast period. A ventriculoperitoneal (VP) shunt reduces pressure exerted on the brain by fluid accumulation by diverting CSF from the brain's ventricles into the peritoneal cavity, the slot in the abdomen near digestive organs. Ventriculoperitoneal (VP) shunts are among the most commonly used tools for treating hydrocephalus. According to a research paper published in the National Center for Biotechnology Information (NCBI), a VP shunt has a high impact in advanced neurosurgical patient care. VP shunt can be lifesaving for benign disorders.

The US hydrocephalus shunts market, by age group, is segmented into pediatric and adults. The pediatric segment led the market in 2022 and is expected to retain its dominance during the forecast period by 2030. Hydrocephalus is the most common cause of brain surgery in children. A prenatal sonogram or MRI scan is recommended to identify hydrocephalus in a growing fetus. Infants generally show signs of progressive macrocephaly, whereas children older than 2 years show signs and symptoms of intracranial hypertension. Pediatric hydrocephalus can be dangerous if left untreated. Nevertheless, with early diagnosis and treatment, children often lead regular and healthy lives. According to the Hydrocephalus Association, 1-2 of every 1,000 babies have hydrocephalus in the US.

The US hydrocephalus shunts market, by end user, is segmented into hospitals, ambulatory surgical centers, others. The hospitals segment led the market in 2022 and is expected to retain its dominance during the forecast period by 2030. Hospitals provide healthcare to people through complicated but specialized scientific equipment. These facilities are classified into general, specialty, or government organizations. Hospitals serve a significant role by providing medical services to patient populations suffering from various diseases. The growth of the US hydrocephalus shunt market for the hospitals segment is attributed to an increase in the number of neurological surgeries, and a surge in demand for valves and neuronavigation systems in these facilities to treat the condition. Additionally, an increasing number of hospitals providing hydrocephalus surgeries in developed and developing countries is expected to boost the market growth in the future.

US Hydrocephalus Shunts Market: Key Players

B. Braun SE, Sophysa SA, Integra LifeSciences Holdings Corp, KANEKA MEDIX CORP, Medtronic Plc, Natus Medical Inc, Anuncia Inc, Desu Medical are among the leading companies operating in the US hydrocephalus shunts market.

A few of the key primary and secondary sources referred to while preparing the report on the US hydrocephalus shunts market are the World Health Organization (WHO), FDA (Food and Drug Administration), Hydrocephalus Association, National Institute of Neurological Disorders and Stroke (NINDS), University of California, Los Angeles Health Organization, National Center for Biotechnology Information, Children's Health Orange County, amongst others.

Reasons to Buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hydrocephalus shunts market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the US hydrocephalus shunts market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth US market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Research Methodology

• 2.1 Coverage
• 2.2 Secondary Research
• 2.3 Primary Research

3. US Hydrocephalus Shunts Market - Market Landscape

• 3.1 Overview
  • 3.1.1 US PEST Analysis

4. US Hydrocephalus Shunts Market - Key Market Dynamics

• 4.1 Market Drivers
  • 4.1.1 Surging Prevalence of Hydrocephalus
  • 4.1.2 Advancements in Hydrocephalus Management Devices
• 4.2 Market Restraints
  • 4.2.1 High Cost of Treatments and Need for Revised Surgeries
• 4.3 Market Opportunities
  • 4.3.1 Rise in Funding for R&D and Trials Associated with Hydrocephalus Shunts
• 4.4 Future Trends
  • 4.4.1 Increasing Partnerships to Aid in Smart Functioning of Hydrocephalus Shunts
• 4.5 Impsact Analysis

5. US Hydrocephalus Shunts Market - Country Analysis

• 5.1 US Hydrocephalus Shunts Market
  • 5.1.1 Overview

6. Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by Product

• 6.1 Overview
• 6.2 US Hydrocephalus Shunts Market Revenue Share, by Product 2022 & 2030 (%)
• 6.3 Hydrocephalus Valves
  • 6.3.1 Overview
  • 6.3.2 Hydrocephalus Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.1 Adjustable Pressure Valves
      • 6.3.2.1.1 Overview
      • 6.3.2.1.2 Adjustable Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
    • 6.3.2.2 Fix Pressure Valves
      • 6.3.2.2.1 Overview
      • 6.3.2.2.2 Fix Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 6.4 Hydrocephalus Catheters
  • 6.4.1 Overview
  • 6.4.2 Hydrocephalus Catheters: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 6.5 Neuronavigation Systems
  • 6.5.1 Overview
  • 6.5.2 Neuronavigation Systems: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 6.6 Others
  • 6.6.1 Overview
  • 6.6.2 Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

7. US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by Type

• 7.1 Overview
• 7.2 US Hydrocephalus Shunts Market Revenue Share, by Type 2022 & 2030 (%)
• 7.3 Ventriculoperitoneal
  • 7.3.1 Overview
  • 7.3.2 Ventriculoperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 7.4 Ventriculoatrial
  • 7.4.1 Overview
  • 7.4.2 Ventriculoatrial: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 7.5 Ventriculopleural
  • 7.5.1 Overview
  • 7.5.2 Ventriculopleural: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 7.6 Lumboperitoneal
  • 7.6.1 Overview
  • 7.6.2 Lumboperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

8. US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by Age Group

• 8.1 Overview
• 8.2 US Hydrocephalus Shunts Market Revenue Share, by Age Group 2022 & 2030 (%)
• 8.3 Pediatric
  • 8.3.1 Overview
  • 8.3.2 Pediatric: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 8.4 Adults
  • 8.4.1 Overview
  • 8.4.2 Adults: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

9. US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 - by End User

• 9.1 Overview
• 9.2 US Hydrocephalus Shunts Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Hospitals
  • 9.3.1 Overview
  • 9.3.2 Hospitals: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 9.4 Ambulatory Surgical Centers
  • 9.4.1 Overview
  • 9.4.2 Ambulatory Surgical Centers: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• 9.5 Others
  • 9.5.1 Overview
  • 9.5.2 Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)

10. Industry Landscape

• 10.1 Overview
• 10.2 Organic Developments
  • 10.2.1 Overview

11. Company Profiles

• 11.1 B. Braun SE
  • 11.1.1 Key Facts
  • 11.1.2 Business Description
  • 11.1.3 Products and Services
  • 11.1.4 Financial Overview
  • 11.1.5 SWOT Analysis
  • 11.1.6 Key Developments
• 11.2 Sophysa SA
  • 11.2.1 Key Facts
  • 11.2.2 Business Description
  • 11.2.3 Products and Services
  • 11.2.4 Financial Overview
  • 11.2.5 SWOT Analysis
  • 11.2.6 Key Developments
• 11.3 Integra LifeSciences Holdings Corp
  • 11.3.1 Key Facts
  • 11.3.2 Business Description
  • 11.3.3 Products and Services
  • 11.3.4 Financial Overview
  • 11.3.5 SWOT Analysis
  • 11.3.6 Key Developments
• 11.4 KANEKA MEDIX CORP.
  • 11.4.1 Key Facts
  • 11.4.2 Business Description
  • 11.4.3 Products and Services
  • 11.4.4 Financial Overview
  • 11.4.5 SWOT Analysis
  • 11.4.6 Key Developments
• 11.5 Medtronic Plc
  • 11.5.1 Key Facts
  • 11.5.2 Business Description
  • 11.5.3 Products and Services
  • 11.5.4 Financial Overview
  • 11.5.5 SWOT Analysis
  • 11.5.6 Key Developments
• 11.6 Natus Medical Inc
  • 11.6.1 Key Facts
  • 11.6.2 Business Description
  • 11.6.3 Products and Services
  • 11.6.4 Financial Overview
  • 11.6.5 SWOT Analysis
  • 11.6.6 Key Developments
• 11.7 Anuncia Inc.
  • 11.7.1 Key Facts
  • 11.7.2 Business Description
  • 11.7.3 Products and Services
  • 11.7.4 Financial Overview
  • 11.7.5 SWOT Analysis
  • 11.7.6 Key Developments
• 11.8 Desu Medical
  • 11.8.1 Key Facts
  • 11.8.2 Business Description
  • 11.8.3 Products and Services
  • 11.8.4 Financial Overview
  • 11.8.5 SWOT Analysis
  • 11.8.6 Key Developments

12. Appendix

• 12.1 About The Insight Partners
• 12.2 Glossary of Terms

List Of Tables

• Table 1. Organic Developments Done by Companies
• Table 2. Glossary of Terms

List Of Figures

• Figure 1. US Hydrocephalus Shunts Market Segmentation
• Figure 2. US Hydrocephalus Shunts Market - Key Takeaways
• Figure 3. US: PEST Analysis
• Figure 4. Hydrocephalus Shunts Market: Key Industry Dynamics
• Figure 5. US Hydrocephalus Shunts Market Impact Analysis of Drivers and Restraints
• Figure 6. US Hydrocephalus Shunts Market - Revenue Forecast and Analysis - 2020-2030
• Figure 7. US Hydrocephalus Shunts Market Revenue Share, by Product 2022 & 2030 (%)
• Figure 8. Hydrocephalus Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 9. Adjustable Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 10. Fix Pressure Valves: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 11. Hydrocephalus Catheters: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 12. Neuronavigation Systems: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 13. Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 14. US Hydrocephalus Shunts Market Revenue Share, by Type 2022 & 2030 (%)
• Figure 15. Ventriculoperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 16. Ventriculoatrial: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 17. Ventriculopleural: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 18. Lumboperitoneal: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 19. US Hydrocephalus Shunts Market Revenue Share, by Age Group 2022 & 2030 (%)
• Figure 20. Pediatric: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 21. Adults: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 22. US Hydrocephalus Shunts Market Revenue Share, by End User 2022 & 2030 (%)
• Figure 23. Hospitals: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 24. Ambulatory Surgical Centers: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)
• Figure 25. Others: US Hydrocephalus Shunts Market - Revenue and Forecast to 2030 (US$ Million)